Ropes & Gray: FogPharma Collaborates With ARTBIO to Co-Develop Radiopharmaceutical Cancer Therapies
May 16, 2024
May 16, 2024
BOSTON, Massachusetts, May 16 -- Ropes and Gray, a law firm, issued the following news on May 15, 2024:
Ropes & Gray advised FogPharma in a collaboration with ARTBIO to co-develop new radiopharmaceuticals that would use FogPharma's Helicon peptides platform, designed to better bind to solid tumor cancer targets and block harmful cellular signals with ARTBIO's radiopharmaceutical AlphaDirect platform, designed to delivery radiation precisely into tumors.
Th . . .
Ropes & Gray advised FogPharma in a collaboration with ARTBIO to co-develop new radiopharmaceuticals that would use FogPharma's Helicon peptides platform, designed to better bind to solid tumor cancer targets and block harmful cellular signals with ARTBIO's radiopharmaceutical AlphaDirect platform, designed to delivery radiation precisely into tumors.
Th . . .